278 related articles for article (PubMed ID: 23426590)
21. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.
Stoeckli R; Chanda R; Langer I; Keller U
Obes Res; 2004 Feb; 12(2):346-50. PubMed ID: 14981228
[TBL] [Abstract][Full Text] [Related]
22. Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports.
Ciangura C; Corigliano N; Basdevant A; Mouly S; Declèves X; Touraine P; Lloret-Linares C
Contraception; 2011 Dec; 84(6):649-51. PubMed ID: 22078197
[TBL] [Abstract][Full Text] [Related]
23. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
24. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery.
Vogel JA; Franklin BA; Zalesin KC; Trivax JE; Krause KR; Chengelis DL; McCullough PA
Am J Cardiol; 2007 Jan; 99(2):222-6. PubMed ID: 17223422
[TBL] [Abstract][Full Text] [Related]
25. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.
Schernthaner GH; Kopp HP; Kriwanek S; Krzyzanowska K; Satler M; Koppensteiner R; Schernthaner G
Obes Surg; 2006 Jun; 16(6):709-15. PubMed ID: 16756729
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.
Gould JC; Garren MJ; Boll V; Starling JR
Surgery; 2006 Oct; 140(4):524-9; discussion 529-31. PubMed ID: 17011899
[TBL] [Abstract][Full Text] [Related]
27. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects.
Holdstock C; Lind L; Engstrom BE; Ohrvall M; Sundbom M; Larsson A; Karlsson FA
Int J Obes (Lond); 2005 Oct; 29(10):1275-80. PubMed ID: 16010285
[TBL] [Abstract][Full Text] [Related]
28. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.
Serpa Neto A; Bianco Rossi FM; Dal Moro Amarante R; Alves Buriti N; Cunha Barbosa Saheb G; Rossi M
J Nephrol; 2009; 22(5):637-46. PubMed ID: 19809997
[TBL] [Abstract][Full Text] [Related]
29. Effect of bariatric surgery on sulphur amino acids and glutamate.
Aasheim ET; Elshorbagy AK; Diep LM; Søvik TT; Mala T; Valdivia-Garcia M; Olbers T; Bøhmer T; Birkeland KI; Refsum H
Br J Nutr; 2011 Aug; 106(3):432-40. PubMed ID: 21554803
[TBL] [Abstract][Full Text] [Related]
30. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
[TBL] [Abstract][Full Text] [Related]
31. Serum amyloid A and obstructive sleep apnea syndrome before and after surgically-induced weight loss in morbidly obese subjects.
Poitou C; Coupaye M; Laaban JP; Coussieu C; Bedel JF; Bouillot JL; Basdevant A; Clément K; Oppert JM
Obes Surg; 2006 Nov; 16(11):1475-81. PubMed ID: 17132414
[TBL] [Abstract][Full Text] [Related]
32. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data.
Jamal M; Wegner R; Heitshusen D; Liao J; Samuel I
Surg Obes Relat Dis; 2011; 7(4):473-9. PubMed ID: 21036105
[TBL] [Abstract][Full Text] [Related]
33. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes.
Geloneze B; Tambascia MA; Pareja JC; Repetto EM; Magna LA; Pereira SG
Obes Surg; 2001 Dec; 11(6):693-8. PubMed ID: 11775566
[TBL] [Abstract][Full Text] [Related]
34. [Gastric bypass surgery effective for morbid obesity].
van Doesburg IA; te Riele WW; Boerma D; Eland IA; Wiezer MJ; van Ramshorst B
Ned Tijdschr Geneeskd; 2010; 154():A1138. PubMed ID: 20482909
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy achieve comparable weight loss at 1 year.
Yaghoubian A; Tolan A; Stabile BE; Kaji AH; Belzberg G; Mun E; Zane R
Am Surg; 2012 Dec; 78(12):1325-8. PubMed ID: 23265120
[TBL] [Abstract][Full Text] [Related]
36. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.
Woelnerhanssen B; Peterli R; Steinert RE; Peters T; Borbély Y; Beglinger C
Surg Obes Relat Dis; 2011; 7(5):561-8. PubMed ID: 21429816
[TBL] [Abstract][Full Text] [Related]
37. Bariatric surgery: Rhabdomyolysis after open Roux-en-Y gastric bypass: a prospective study.
Youssef T; Abd-Elaal I; Zakaria G; Hasheesh M
Int J Surg; 2010; 8(6):484-8. PubMed ID: 20624497
[TBL] [Abstract][Full Text] [Related]
38. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer.
Couce ME; Cottam D; Esplen J; Schauer P; Burguera B
Obes Surg; 2006 Jul; 16(7):870-8. PubMed ID: 16839485
[TBL] [Abstract][Full Text] [Related]
39. Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance.
Riedl M; Vila G; Maier C; Handisurya A; Shakeri-Manesch S; Prager G; Wagner O; Kautzky-Willer A; Ludvik B; Clodi M; Luger A
J Clin Endocrinol Metab; 2008 Jun; 93(6):2307-12. PubMed ID: 18334587
[TBL] [Abstract][Full Text] [Related]
40. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding.
Heinonen MV; Purhonen AK; Miettinen P; Pääkkönen M; Pirinen E; Alhava E; Akerman K; Herzig KH
Regul Pept; 2005 Aug; 130(1-2):7-13. PubMed ID: 15970339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
